Sinew Pharma Inc.: Clinical Trials

1 completed, 1 unknown. 2 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	2	Completed 1, Unknown 1

Follow Sinew Pharma Inc.: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers Panadol®, SafeTynadol® - Hepatitis, Pharmacology	Not applicable	Unknown	Sinew Pharma Inc.	48	2022-10-28	2024-03-27
A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study Panadol®, SafeTynadol® - Acetaminophen Toxicity	Not applicable	Completed	Sinew Pharma Inc.	28	2022-05-19	2023-07-18

Conditions studied

Liver Failure, Acute (2)  ·  Hepatitis (1)

Interventions

Acetaminophen (2)

Countries

Taiwan (2)

Top investigators

TeYu Mr Lin, Dr. (1)